Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
$120.63 SAVE $6.35 Including VAT, plus shipping costs
Certificate of Analysis Included With Every Order
Animal models and relevance to clinical practice
It is utilized off-label in some clinics for wound healing and tendon repair
REDEFINE 4: The Tirzepatide Test The results that attracted the greatest market attention came from REDEFINE 4, an 84-week open-label Phase 3 trial reported in February 2026, in which CagriSema was pitted directly against tirzepatide 15 mg, the highest approved dose of Eli Lillys Zepbound
Study Duration: 50 days
US$ 27.40
US$ 24.90
US$ 28.38
US$ 21.12
US$ 22.64
US$ 20.90
US$ 24.18
